LGND Financials
Ligand Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$231.82
Market Cap
$4.62B
P/E Ratio
37.8
EPS
$6.13
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$268.09M
Gross Profit
$261.50M
Operating Income
$47.20M
Net Income
$124.45M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$1.56B
Total Liabilities
$543.42M
Shareholders Equity
$1.02B
Cash & Equivalents
$174.93M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$49.36M
CapEx
$452000
Free Cash Flow
$48.91M
Profitability Metrics
Gross Margin
64.3%
Operating Margin
0.3%
Net Margin
0.5%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LGND revenue?
LGND's most recent quarterly revenue was $268.09M. Annual revenue can be calculated by summing the four most recent quarters.
Is LGND profitable?
LGND reported a profit of $124.45M in the most recent quarter. The net profit margin is 0.5%.
What is LGND market cap?
LGND has a market capitalization of $4.62B, making it a mid-cap stock.
Does LGND have debt?
View LGND's balance sheet for debt information.
What is LGND cash flow?
LGND's most recent quarterly free cash flow was $48.91M.